Explore the vast range of titles available.

Camels are known carriers for many viral pathogens, including Middle East respiratory syndrome coronavirus (MERS-CoV). It is likely that there are additional, as yet unidentified viruses in camels with the potential to cause disease in humans. In this study, we performed metagenomic sequencing analysis on nasopharyngeal swab samples from 108 MERS-CoV-positive dromedary camels from a live animal market in Abu Dhabi, United Arab Emirates. We obtained a total of 846.72 million high-quality reads from these nasopharyngeal swab samples, of which 2.88 million (0.34%) were related to viral sequences while 512.63 million (60.5%) and 50.87 million (6%) matched bacterial and eukaryotic sequences, respectively. Among the viral reads, sequences related to mammalian viruses from 13 genera in 10 viral families were identified, including Coronaviridae, Nairoviridae, Paramyxoviridae, Parvoviridae, Polyomaviridae, Papillomaviridae, Astroviridae, Picornaviridae, Poxviridae, and Genomoviridae. Some viral sequences belong to known camel or human viruses and others are from potentially novel camel viruses with only limited sequence similarity to virus sequences in GenBank. A total of five potentially novel virus species or strains were identified. Co-infection of at least two recently identified camel coronaviruses was detected in 92.6% of the camels in the study. This study provides a comprehensive survey of viruses in the virome of upper respiratory samples in camels that have extensive contact with the human population.

The evidence justifying the use of acellular dermal matrices (ADMs) in implant-based breast reconstruction (IBBR) is limited. We did a prospective randomised trial to compare the safety of IBBR with an ADM immediately after mastectomy with that of two-stage IBBR. We did an open-label, randomised, controlled trial in eight hospitals in the Netherlands. Eligible women were older than 18 years with breast carcinoma or a gene mutation linked with breast cancer who intended to undergo skin-sparing mastectomy and immediate IBBR. Randomisation was done electronically, stratified per centre and in blocks of ten to achieve roughly balanced groups. Women were assigned to undergo one-stage IBBR with ADM (Strattice, LifeCell, Branchburg, NJ, USA) or two-stage IBBR. The primary endpoint was quality of life and safety was assessed by the occurrence of adverse outcomes. Analyses were done per protocol with logistic regression and generalised estimating equations. This study is registered at Nederlands Trial Register, number NTR5446. 142 women were enrolled between April 14, 2013, and May 29, 2015, of whom 59 (91 breasts) in the one-stage IBBR with ADM group and 62 (92 breasts) in the two-stage IBBR group were included in analyses. One-stage IBBR with ADM was associated with significantly higher risk per breast of surgical complications (crude odds ratio 3·81, 95% CI 2·67–5·43, p<0·001), reoperation (3·38, 2·10–5·45, p<0·001), and removal of implant, ADM, or both (8·80, 8·24–9·40, p<0·001) than two-stage IBBR. Severe (grade 3) adverse events occurred in 26 (29%) of 91 breasts in the one-stage IBBR with ADM group and in five (5%) of 92 in the two-stage IBBR group. The frequency of mild to moderate adverse events was similar in the two groups. Immediate one-stage IBBR with ADM was associated with adverse events and should be considered very carefully. Understanding of selection of patients, risk factors, and surgical and postsurgical procedures needs to be improved. Pink Ribbon, Nuts-Ohra, and LifeCell.

Peste des petits ruminants (PPR) is an important infectious viral disease of domestic small ruminants that threatens the food security and sustainable livelihood of farmers across Middle East, Africa, and Asia. The objective of this research is to analyze the disease’s spread and its impacts on direct government costs through conducting three simulations of different control strategies to reduce and quickly eradicate PPR from the United Arab Emirates in the near future. A Modified Animal Disease Spread Model was developed in this study to suit the conditions of the United Arab Emirates. The initial scenario represents when mass vaccination is ceased, and moderate movement restrictions are applied. The second scenario is based on mass vaccination and stamping out the disease, whereas the third simulation scenario assumes mass and ring vaccination when needed, very strict movement control, and stamping out. This study found that the third scenario is the most effective in controlling and eradicating PPR from the UAE. The outbreak duration in days was reduced by 57% and the number of infected animals by 77% when compared to the other scenarios. These results are valuable to the country’s animal health decision-makers and the government’s efforts to report to the World Animal Health Organization (OIE) regarding the progress made towards declaration of the disease’s eradication. They are also useful to other concerned entities in other Middle Eastern, North African, and Asian countries where the disease is spreading.

Background Chicken anemia virus (CAV) is the causative agent of chicken infectious anemia (CIA). A high prevalence of CAV has been reported in China. However, VP1 sequences of Chinese isolates show no clear genotype clustering or correlation with geographic origin. Therefore, the present study aimed to detect and characterize CAV isolates from China based on sequence and phylogenetic analysis of the VP1, VP2 and VP3 genes. Results Of 460 spleen samples tested by PCR, 47 (10.22%) were found to be positive for CAV. A total of 25 CAV, approximately full genomes, from different commercial farms were characterized. Phylogenetic analysis of the Chinese CAV sequences together with strains from different countries resulted in four distinct groups (A-D) with significant high bootstrap values. The Chinese viral sequences were located as four different clusters within groups A and D. All the Chinese CAV genomes characterized in this study had glutamine (Q) at amino acid position 394, which indicated that all are highly pathogenic. Mutations associated with attenuation and weaker reactivity with monoclonal antibody 2A9 were absent in the Chinese sequences. Conclusions We revealed that CAV prevalence was lower than that reported previously in commercial farms in China. We also showed four distinct sequence groups (A-D), and genetic variability in local CAV sequences that could be divided into four groups based on phylogenetic analysis.

Middle East Respiratory Syndrome (MERS-CoV) is a coronavirus-caused viral respiratory infection initially detected in Saudi Arabia in 2012. In UAE, high seroprevalence (97.1) of MERS-CoV in camels was reported in several Emirate of Abu Dhabi studies, including camels in zoos, public escorts, and slaughterhouses. The objectives of this research include simulation of MERS-CoV spread using a customized animal disease spread model (i.e., customized stochastic model for the UAE; analyzing the MERS-CoV spread and prevalence based on camels age groups and identifying the optimum control MERS-CoV strategy. This study found that controlling animal mobility is the best management technique for minimizing epidemic length and the number of affected farms. This study also found that disease dissemination differs amongst camels of three ages: camel kids under the age of one, young camels aged one to four, and adult camels aged four and up; because of their immunological state, kids, as well as adults, had greater infection rates. To save immunization costs, it is advised that certain age groups be targeted and that intense ad hoc unexpected vaccinations be avoided. According to the study, choosing the best technique must consider both efficacy and cost.

Peste des petits ruminants (PPR) is a contagious and economically important transboundary viral disease of small ruminants. The United Arab Emirates (UAE) national animal health plan aimed to control and eradicate PPR from the country by following the global PPR control and eradication strategy which adopts small ruminants’ mass vaccination to eradicate the disease from the globe by 2030. A smart vaccination approach, which is less expensive and has longer-term sustainable benefits, is needed to accelerate the eradication of PPR. In this study, a mathematical algorithm was developed based on animals’ identification and registration data, belonging to the Abu Dhabi Agriculture and Food Safety Authority (ADAFSA), and other different parameters related to PPR risk occurrence. The latter included animal holding vaccination history, the number of animals per holding, forecasting of the number of animals and newborns per holding, the proximity of an animal holding to a PPR outbreak and the historical animal holding owner vaccination rejection attitude. The developed algorithm successfully prioritized animal holdings at risk of PPR infection within Abu Dhabi Emirate to be targeted by vaccination. This in turn facilitated the mobilization of field vaccination teams to target specific sheep and goat holdings to ensure the generation of immunity against the disease on a risk-based approach. The vaccination coverage of the targeted livestock population was increased to 86% and the vaccination rejection attitude was reduced by 35%. The duration of the vaccination campaign was reduced to 30 compared to 70 working days and hence can alleviate the depletion of human and logistic resources commonly used in classical mass vaccination campaigns. The results obtained from implementing the algorithm-based PPR vaccination campaign will reduce the negative impact of PPR on the UAE livestock sector and accelerate the achievement of the national PPR eradication plan requirements.

Despite the annual vaccination of livestock against foot and mouth disease (FMD) in the United Arab Emirates (UAE), outbreaks of the disease continue to be reported. The effective control of field outbreaks by vaccination requires that the vaccines used are antigenically matched to circulating field FMD viruses. In this study, a vaccine matching analysis was performed using the two-dimensional virus neutralization test (VNT) for three field isolates belonging to the O/ME-SA/PanAsia-2/ANT-10 and O/ME-SA/SA-2018 lineages collected from different FMD outbreaks that occurred within the Abu Dhabi Emirate in 2021 affecting Arabian oryx (Oryx leucoryx), goat, and sheep. In addition, post-vaccination antibodies in sheep and goats were measured using solid-phase competitive ELISA (SPCE) for FMDV serotypes A and O at five months after a single vaccine dose and a further 28 days later after a second dose of the FMD vaccine. An analysis of vaccine matching revealed that five out of the six vaccine strains tested were antigenically matched to the UAE field isolates, with r1-values ranging between 0.32 and 0.75. These results suggest that the vaccine strains (O-3039 and O1 Manisa) included in the FMD vaccine used in the Abu Dhabi Emirate are likely to provide protection against outbreaks caused by the circulating O/ME-SA/PanAsia-2/ANT-10 and O/ME-SA/SA-2018 lineages. All critical residues at site 1 and site 3 of VP1 were conserved in all isolates, although an analysis of the VP1-encoding sequences revealed 14–16 amino acid substitutions compared to the sequence of the O1 Manisa vaccine strain. This study also reports on the results of post-vaccination monitoring where the immunization coverage rates against FMDV serotypes A and O were 47% and 69% five months after the first dose of the FMD vaccine, and they were increased to 81 and 88%, respectively, 28 days after the second dose of the vaccine. These results reinforce the importance of using a second booster dose to maximize the impact of vaccination. In conclusion, the vaccine strains currently used in Abu Dhabi are antigenically matched to circulating field isolates from two serotype O clades (O/ME-SA/PanAsia-2/ANT-10 sublineage and O/ME-SA/SA-2018 lineage). The bi-annual vaccination schedule for FMD in the Abu Dhabi Emirate has the potential to establish a sufficient herd immunity, especially when complemented by additional biosecurity measures for comprehensive FMD control. These findings are pivotal for the successful implementation of the region’s vaccination-based FMD control policy, showing that high vaccination coverage and the wide-spread use of booster doses in susceptible herds is required to achieve a high level of FMDV-specific antibodies in vaccinated animals.

Foot-and-mouth disease (FMD) is an endemic disease in the United Arab Emirates (UAE) in both wild and domestic animals. Despite this, no systematic FMD outbreak investigation accompanied by molecular characterisation of FMD viruses (FMDVs) in small ruminants or cattle has been performed, and only a single report that describes sequences for FMDVs in wildlife from the Emirate has been published. In this study, FMD outbreaks that occurred in 2021 in five animal farms and one animal market in the Emirate of Abu Dhabi were investigated. Cases involved sheep, goats, and cattle, as well as Arabian oryx (Oryx leucoryx). Twelve samples were positive for FMDV via RT-qPCR, and four samples (Arabian oryx n = 1, goat n = 2, and sheep n = 1) were successfully genotyped using VP1 nucleotide sequencing. These sequences shared 88~98% identity and were classified within the serotype O, Middle East–South Asia topotype (O/ME-SA). Phylogenetic analysis revealed that the Arabian oryx isolate (UAE/2/2021) belonged to the PanAsia-2 lineage, the ANT-10 sublineage, and was closely related to the FMDVs recently detected in neighbouring countries. The FMDV isolates from goats (UAE/10/2021 and UAE/11/2021) and from sheep (UAE/14/2021) formed a monophyletic cluster within the SA-2018 lineage that contained viruses from Bangladesh, India, and Sri Lanka. This is the first study describing the circulation of the FMDV O/ME-SA/SA-2018 sublineage in the UAE. These data shed light on the epidemiology of FMD in the UAE and motivate further systematic epidemiological studies and genomic sequencing to enhance the ongoing national animal health FMD control plan.

Background: Peste des petits ruminants (PPR) is an acute or subacute contagious trans-boundary viral disease causing high morbidity and mortality in domestic and wild small ruminants. The national UAE-PPR control and eradication plan follows the PPR Global Control and Eradication Strategy (PPR GCES) and relies on the annual mass vaccination of small ruminants to eradicate the disease from the country by 2030. Despite the immunization effort against PPR, the vaccination coverage reached 65% at maximum, which necessitates conducting a post-vaccination evaluation (PVE) study at the national level. Methods: Using multistage random sampling to assess the PPR vaccine and vaccination effectiveness, protocol (2) of the PPR GCES, using two serosurveys; serosurvey (1) (pre-vaccination) at day 0 before vaccination, to assess the primary PPR serological investigation, and serosurvey (2) at (30–90) days post-PPR vaccination, to evaluate the immune response, were carried out from September to December 2024 across the seven Emirates of the UAE. The nucleoprotein-based competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect PPR antibodies in a total of 1592 and 1589 sera samples collected, respectively, before and after vaccination from different (n = 163) sheep and goats holdings (epi-unit) distributed in the different Emirates of the UAE. Results: In serosurvey (1). prior to vaccination, out of the total 1592 samples tested (839 goats and 753 sheep), 833 animals (52.32%) were found to be seropositive for PPR antibodies. In contrast, in serosurvey (2), after vaccination, 1490 (93.77%) animals were found to be seropositive out of the total 1589 small ruminants (825 goats and 764 sheep) tested by c-ELISA. A statistically significant increase (41.45%) in the overall seroprevalence from (52.32%) pre-vaccination to (93.77%) post-vaccination was observed. Post-vaccination, 93.87% (n = 153) of the vaccinated epi-units achieved more than 70% seroprevalence compared to 43.56% (n = 71) before vaccination. Prediction analysis showed that all the seven UAE Emirates require 1.2 years maximum to reach 100% immune-protection levels. Conclusions: An efficient PPR vaccine was used to immunize small ruminants in the UAE. Higher (89.47–100%) post-vaccination herd immunity than the threshold recommended by the PPR GCES (>80% immunity) was attained, which can efficiently break the spread of PPRV within the UAE. To enhance the eradication of PPR I the UAE, conducting mass vaccination campaigns targeting over the (95%) immunization coverage of eligible animals for the next three years is recommended to attain the requested sustained (>80%) immunity at the animals holding level.

Background Chicken anemia virus (CAV) is the causative agent of chicken infectious anemia. CAV putative intergenotypic recombinants have been reported previously. This fact is based on the previous classification of CAV sequences into three genotypes. However, it is unknown whether intersubtype recombination occurs between the recently reported four CAV genotypes and five subtypes of genome sequences. Results Phylogenetic analysis, together with a variety of computational recombination detection algorithms, was used to investigate CAV approximately full genomes. Statistically significant evidence of intersubtype recombination was detected in the parent-like and two putative CAV recombinant sequences. This event was shown to occur between CAV subgroup A1 and A2 sequences in the phylogenetic trees. Conclusions We revealed that intersubtype recombination in CAV genome sequences played a role in generating genetic diversity within the natural population of CAV.